Evolving HER2-positive breast cancer treatment to improve survival rate Evolving HER2-positive breast cancer treatment to improve survival rate
MONDAY, NOVEMBER 25, 2024
Treatment for human epidermal growth factor receptor 2 (HER2)-positive breast cancer continues to evolve, resulting in improved survival and enhancing the quality of life for patients, medical experts said.